EGFR mutation testing is a crucial diagnostic tool used to identify specific mutations in the epidermal growth factor receptor gene, which can guide targeted therapy decisions in non-small cell lung cancer patients. This testing helps in predicting response to EGFR tyrosine kinase inhibitors, improving treatment outcomes and personalizing cancer care.